Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 7(11): e49435, 2012.
Article in English | MEDLINE | ID: mdl-23185331

ABSTRACT

The human gammaherpesvirus Kaposi sarcoma-associated herpesvirus is strongly linked to neoplasms of endothelial and B-cell origin. The majority of tumor cells in these malignancies are latently infected, and latency genes are consequently thought to play a critical role in virus-induced tumorigenesis. One such factor is kshv-miR-K12-11, a viral microRNA that is constitutively expressed in cell lines derived from KSHV-associated tumors, and that shares perfect homology of its seed sequence with the cellular miR-155. Since miR-155 is overexpressed in a number of human tumors, it is conceivable that mimicry of miR-155 by miR-K12-11 may contribute to cellular transformation in KSHV-associated disease. Here, we have performed a side-by-side study of phenotypic alterations associated with constitutive expression of either human miR-155 or viral miR-K12-11 in bone marrow-derived hematopoietic stem cells. We demonstrate that retroviral-mediated gene transfer and hematopoietic progenitor cell transplantation into C57BL/6 mice leads to increased B-cell fractions in lymphoid organs, as well as to enhanced germinal center formation in both microRNA-expressing mouse cohorts. We furthermore identify Jarid2, a component of Polycomb repressive complex 2, as a novel validated target of miR-K12-11, and confirm its downregulation in miR-K12-11 as well as miR-155 expressing bone marrow cells. Our findings confirm and extend previous observations made in other mouse models, and underscore the notion that miR-K12-11 may have arisen to mimic miR-155 functions in KSHV-infected B-cells. The expression of miR-K12-11 may represent one mechanism by which KSHV presumably aims to reprogram naïve B-cells towards supporting long-term latency, which at the same time is likely to pre-dispose infected lymphocytes to malignant transformation.


Subject(s)
B-Lymphocytes/virology , Herpesvirus 8, Human/metabolism , MicroRNAs/metabolism , Sarcoma, Kaposi/metabolism , Animals , B-Lymphocytes/cytology , Bone Marrow Cells/cytology , Cell Proliferation , Gene Transfer Techniques , HEK293 Cells , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/virology , Humans , Mice , Mice, Inbred C57BL , Plasmids/metabolism , RNA, Viral/metabolism
2.
PLoS One ; 7(2): e31576, 2012.
Article in English | MEDLINE | ID: mdl-22348110

ABSTRACT

Over the previous years, comprehensive studies on antiretroviral drugs resulted in the successful introduction of highly active antiretroviral therapy (HAART) into clinical practice for treatment of HIV/AIDS. However, there is still need for new therapeutic approaches, since HAART cannot eradicate HIV-1 from the infected organism and, unfortunately, can be associated with long-term toxicity and the development of drug resistance. In contrast, novel gene therapy strategies may have the potential to reverse the infection by eradicating HIV-1. For example, expression of long terminal repeat (LTR)-specific recombinase (Tre-recombinase) has been shown to result in chromosomal excision of proviral DNA and, in consequence, in the eradication of HIV-1 from infected cell cultures. However, the delivery of Tre-recombinase currently depends on the genetic manipulation of target cells, a process that is complicating such therapeutic approaches and, thus, might be undesirable in a clinical setting. In this report we demonstrate that E.coli expressed Tre-recombinases, tagged either with the protein transduction domain (PTD) from the HIV-1 Tat trans-activator or the translocation motif (TLM) of the Hepatitis B virus PreS2 protein, were able to translocate efficiently into cells and showed significant recombination activity on HIV-1 LTR sequences. Tre activity was observed using episomal and stable integrated reporter constructs in transfected HeLa cells. Furthermore, the TLM-tagged enzyme was able to excise the full-length proviral DNA from chromosomal integration sites of HIV-1-infected HeLa and CEM-SS cells. The presented data confirm Tre-recombinase activity on integrated HIV-1 and provide the basis for the non-genetic transient application of engineered recombinases, which may be a valuable component of future HIV eradication strategies.


Subject(s)
Cell Membrane Permeability , DNA Repair , DNA, Viral/isolation & purification , HIV Infections/therapy , HIV-1/genetics , Recombinases/administration & dosage , Cloning, Molecular , DNA, Viral/metabolism , Escherichia coli/genetics , HIV Long Terminal Repeat , HeLa Cells , Humans , Recombinant Proteins/therapeutic use , Recombinases/metabolism , Recombinases/therapeutic use
3.
J Invest Dermatol ; 131(1): 20-9, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20827281

ABSTRACT

Here, we report a comprehensive investigation of changes in microRNA (miRNA) expression profiles on human keratinocyte (HK) differentiation in vitro and in vivo. We have monitored expression patterns of 377 miRNAs during calcium-induced differentiation of primary HKs, and have compared these patterns with miRNA expression profiles of epidermal stem cells, transient amplifying cells, and terminally differentiated HKs from human skin. Apart from the previously described miR-203, we found an additional nine miRNAs (miR-23b, miR-95, miR-210, miR-224, miR-26a, miR-200a, miR-27b, miR-328, and miR-376a) that are associated with HK differentiation in vitro and in vivo. In situ hybridization experiments confirmed miR-23b as a marker of HK differentiation in vivo. Additionally, gene ontology analysis and functional validation of predicted miRNA targets using 3'-untranslated region-luciferase assays suggest that multiple miRNAs that are upregulated on HK differentiation cooperate to regulate gene expression during skin development. Our results thus provide the basis for further analysis of miRNA functions during epidermal differentiation.


Subject(s)
Epidermis , Genetic Markers , Keratinocytes/cytology , Keratinocytes/physiology , MicroRNAs/metabolism , Biopsy , Calcium/pharmacology , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cells, Cultured , Down-Regulation/genetics , Epidermal Cells , Epidermis/growth & development , Epidermis/physiology , Female , Gene Expression Regulation, Developmental , Humans , In Vitro Techniques , Receptor, Endothelin A/genetics , Trans-Activators/genetics , Up-Regulation/genetics
4.
PLoS Pathog ; 6(8): e1001063, 2010 Aug 19.
Article in English | MEDLINE | ID: mdl-20808852

ABSTRACT

Cellular and viral microRNAs (miRNAs) are involved in many different processes of key importance and more than 10,000 miRNAs have been identified so far. In general, relatively little is known about their biological functions in mammalian cells because their phenotypic effects are often mild and many of their targets still await identification. The recent discovery that Epstein-Barr virus (EBV) and other herpesviruses produce their own, barely conserved sets of miRNAs suggests that these viruses usurp the host RNA silencing machinery to their advantage in contrast to the antiviral roles of RNA silencing in plants and insects. We have systematically introduced mutations in EBV's precursor miRNA transcripts to prevent their subsequent processing into mature viral miRNAs. Phenotypic analyses of these mutant derivatives of EBV revealed that the viral miRNAs of the BHRF1 locus inhibit apoptosis and favor cell cycle progression and proliferation during the early phase of infected human primary B cells. Our findings also indicate that EBV's miRNAs are not needed to control the exit from latency. The phenotypes of viral miRNAs uncovered by this genetic analysis indicate that they contribute to EBV-associated cellular transformation rather than regulate viral genes of EBV's lytic phase.


Subject(s)
Apoptosis/genetics , B-Lymphocytes/virology , Cell Transformation, Viral/genetics , Herpesvirus 4, Human/genetics , MicroRNAs/genetics , Viral Proteins/genetics , B-Lymphocytes/pathology , Base Sequence , Cell Cycle/genetics , Epstein-Barr Virus Infections/genetics , Epstein-Barr Virus Infections/virology , Genes, Viral , Humans , Molecular Sequence Data , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Virus Latency/genetics
5.
J Virol ; 84(2): 716-28, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19889779

ABSTRACT

MicroRNAs (miRNAs) are small, noncoding RNAs which posttranscriptionally regulate gene expression. The current release of the miRNA registry lists 16 viruses which encode a total of 146 miRNA hairpins. Strikingly, 139 of these are encoded by members of the herpesvirus family, suggesting an important role for miRNAs in the herpesvirus life cycle. However, with the exception of 7 miRNA hairpins known to be shared by Epstein-Barr virus (EBV) and the closely related rhesus lymphocryptovirus (rLCV), the known herpesvirus miRNAs show little evidence of evolutionary conservation. We have performed a global analysis of miRNA conservation among gammaherpesviruses which is not limited to family members known to encode miRNAs but includes also those which have not been previously analyzed. For this purpose, we have performed a computational prediction of miRNA candidates of all fully sequenced gammaherpesvirus genomes, followed by sequence/structure alignments. Our results indicate that gammaherpesvirus miRNA conservation is limited to two pairs of viral genomes. One is the already-known case of EBV and rLCV. These viruses, however, share significantly more miRNAs than previously thought, as we identified and experimentally verified 10 novel conserved as well as 7 novel nonconserved rLCV pre-miRNA hairpins. The second case consists of rhesus rhadinovirus (RRV), which is predicted to share at least 9 pre-miRNAs with the closely related Japanese macaque herpesvirus (JMHV). Although several other gammaherpesviruses are predicted to encode large numbers of clustered miRNAs at conserved genomic loci, no further examples of evolutionarily conserved miRNA sequences were found.


Subject(s)
Computational Biology/methods , Conserved Sequence , Evolution, Molecular , Gammaherpesvirinae/genetics , MicroRNAs , Animals , Base Sequence , Gammaherpesvirinae/classification , Genome, Viral , Herpesvirus 4, Human/genetics , Humans , Lymphocryptovirus/genetics , Macaca mulatta/virology , MicroRNAs/chemistry , MicroRNAs/genetics , MicroRNAs/metabolism , Molecular Sequence Data , Rhadinovirus/genetics , Sequence Alignment
6.
Mol Pharmacol ; 73(5): 1513-29, 2008 May.
Article in English | MEDLINE | ID: mdl-18272749

ABSTRACT

Inhibition of lipolysis by palmitate, H(2)O(2), and the antidiabetic sulfonylurea drug, glimepiride, in rat adipocytes has been shown previously to rely on the concerted degradation of cAMP by the glycosylphosphatidylinositol (GPI)-anchored phosphodiesterase Gce1 and 5'-nucleotidase CD73, which both gain access to the lipid droplets (LDs). The present report demonstrates the translocation of Gce1 and CD73, harboring the intact GPI anchor, from detergent-insoluble glycolipid-enriched plasma membrane domains (DIGs) to the LDs in response to palmitate, H(2)O(2), and glimepiride by analysis of their steady-state distribution using photoaffinity labeling and activity determination as well as of their redistribution after pulse or equilibrium metabolic labeling. We were surprised to find that palmitate, H(2)O(2), and glimepiride induced the activation of the GPI-specific phospholipase C (GPI-PLC) at DIGs of rat adipocytes, leading to anchorless Gce1 and CD73. Inhibition of the GPI-PLC or the presence of nonhydrolyzable substrate analogs of Gce1 and CD73 interfered with the palmitate-, H(2)O(2)-, and glimepiride-induced 1) lipolytic cleavage of Gce1 and CD73, 2) translocation of their GPI-anchored versions from DIGs to LDs, 3) up-regulation of cAMP degradation, and 4) inhibition of lipolysis. These data suggest a novel insulin-independent antilipolytic mechanism in rat adipocytes, which relies on the palmitate-, H(2)O(2)-, and glimepiride-induced and GPI-PLC-dependent translocation of (c)AMP-degrading GPI-anchored proteins from the adipocyte plasma membrane to LDs. The findings may shed new light on the biogenesis and degradation of LDs in response to physiological and pharmacological stimuli.


Subject(s)
Adipocytes/enzymology , Glycosylphosphatidylinositols/metabolism , Hydrogen Peroxide/pharmacology , Membrane Microdomains/metabolism , Palmitates/pharmacology , Sulfonylurea Compounds/pharmacology , 5'-Nucleotidase/metabolism , Adenosine/metabolism , Adipocytes/drug effects , Adipocytes/metabolism , Animals , Cattle , Cholesterol/deficiency , Cyclic AMP/metabolism , Glucose Oxidase/pharmacology , Intracellular Space/drug effects , Intracellular Space/metabolism , Lipid Metabolism/drug effects , Lipolysis/drug effects , Membrane Microdomains/drug effects , Phosphoric Diester Hydrolases/metabolism , Protein Transport/drug effects , Rats , Triglycerides/biosynthesis , Type C Phospholipases/metabolism
7.
AIDS Res Hum Retroviruses ; 23(11): 1377-86, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18184081

ABSTRACT

Multiple factors are known to contribute to nonprogressive disease in long-term nonprogressors (LTNP). We previously selected LTNPs, in which broadly neutralizing antibodies against HIV-1 very likely contribute to disease prevention. Here, we characterize those LTNPs further. We analyzed sequences of the viral genes env, nef, vpr, tat, and rev as well as the cellular ccr5, HLA-B*5701, and HLA-B*27 genes derived from eight LTNPs, as mutations in these genes have been associated with the LTNP status in some studies. Furthermore, we compared the replication rates of recombinant reporter viruses carrying envelope proteins from LTNPs to control viruses from patients with similar CD4 count and viral load. Concerning the cellular factors, none of the eight LTNPs showed the 32-base pair deletion in the ccr5 gene, and HLA-B*5701 and HLA-B*27 alleles were detected in only one LTNP, respectively. The reading frames for the regulatory genes nef, vpr, tat, and rev were all open. Although Env sequences from LTNPs differed from those of control patients with respect to the length of variable domains and the number of N-glycosylation sites, these differences were not statistically significant and did not lead to differences in infectivity of recombinant reporter viruses.


Subject(s)
HIV Infections/immunology , HIV Infections/virology , HIV Long-Term Survivors , Immunity, Innate/genetics , Cell Line , Genes, env/genetics , HLA-B Antigens/genetics , Humans , Receptors, CCR5/genetics , Virus Replication , nef Gene Products, Human Immunodeficiency Virus/genetics , tat Gene Products, Human Immunodeficiency Virus/genetics , vpr Gene Products, Human Immunodeficiency Virus/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...